PACE model

Featuring:

Innovative additional ICER reflecting changing clinical practice through market share displacement:
– Helps you to demonstrate the impact of your product on the market, with a weighted ICER taking into account market share displacement
– Unlike a traditional ICER, The Adelphi Values | PACE model™ compares your product to the entire market, not just a single comparator in the same indication
Exploration of relevant scenarios through a streamlined process to gain/maintain reimbursement in your product’s specific market conditions:
– Save budget compared to additional modelling work
– Common access pathways such as risk-sharing agreements and patient access schemes
can be investigated, to the benefit of decision makers, patients and clients